Patents
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
05/2007
05/29/2007US7223888 Mu opioid receptor ligands: methods of use and synthesis
05/29/2007US7223879 Reactibng transition metal with boron compound and sulfonate compound
05/29/2007US7223355 Functional additive having UV-absorbing substituent and ink composition containing the same
05/29/2007CA2214565C New cryptophycins from synthesis
05/24/2007WO2007057909A1 Androgen-receptor (ar) ligands for use in the treatment and diagnosis of ar-related pathologies
05/24/2007US20070117803 Cyclohexyl-1,4-diamine compounds
05/24/2007US20070117797 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
05/23/2007CN1968714A Lipids, lipid complexes and use thereof
05/22/2007US7220884 Hydroaminomethylation of olefins
05/22/2007US7220875 Amino acid derived prodrugs of propofol, compositions and uses thereof
05/22/2007US7220781 Meta-benzamidine derivatives as serine protease inhibitors
05/18/2007WO2007056469A2 Certain chemical entities, compositions, and methods
05/18/2007WO2006138641A3 Manufacturing process for tigecycline
05/17/2007US20070112201 Intermediates to a copper bisoxazoline catalyst for asymmetric synthesis of agrochemical or pharmaceutical intermediates such as insecticides; reacting a cycloalkylidenemalonic diester with an aminoalcohol to form amide intermediate; cyclization to ligand e.g. 1,1-bis[2-[tert-butyloxazoline]]cyclopropane
05/17/2007US20070112200 Non-racemic hexafluoreleucine,and methods of making and using it
05/17/2007US20070111927 Peptoid compounds
05/17/2007US20070111926 Conjugation of peptides
05/16/2007CN1964955A Small molecules for treatment of hypercholesterolemia and related diseases
05/16/2007CN1964942A Process for preparing 2-oxo-1-pyrrolidine derivatives by intramolecular allylation
05/16/2007CN1961885A Tetracycline derivatives and methods of use thereof
05/16/2007CN1315787C Theanine preparing process
05/15/2007US7217826 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate
05/15/2007US7217728 For therapy of reperfusion injury
05/15/2007US7217706 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence
05/10/2007WO2007052938A1 Alkylcarbamoyl naphthalenyloxy- octenoylhydroxyamide derivatives having inhibitory activity against histone deacetylase and preparation thereof
05/10/2007WO2007025709A3 Organic compounds
05/10/2007US20070105958 Compounds for the treatment of metabolic disorders
05/10/2007US20070105941 Substituted cyclohexylcarboxylic acid amide compounds
05/10/2007US20070105131 Sequencing of surface immobilized polymers utilizing microfluorescence detection
05/10/2007CA2628040A1 Alkylcarbamoyl naphthalenyloxy- octenoylhydroxyamide derivatives having inhibitory activity against histone deacetylase and preparation thereof
05/09/2007EP1781597A1 O-aminophenol derivatives and dyes containing these compounds
05/09/2007EP1781596A1 Amino acid derived prodrugs of propofol compositions and uses thereof
05/09/2007EP1781595A1 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
05/09/2007CN1314659C Method for preparing ioxitalamic acid
05/08/2007US7214715 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques
05/08/2007US7214669 Tetracycline derivatives and methods of use thereof
05/08/2007US7214384 Lipid-conjugated polyamide compounds
05/08/2007CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
05/08/2007CA2301187C Process for purification or recovery of sweetener
05/03/2007WO2007049724A1 Connection member and harness connection body using the connection member
05/03/2007WO2007049123A1 Histamine-3 receptor antagonists
05/02/2007EP1778651A2 Multivalent chelators for modifying and organizing of target molecules
05/02/2007EP1778621A1 Preparation of iodixanol
05/02/2007EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
05/02/2007CN1956968A Aryl glycinamide derivatives and their use as NK1 antagonists and 5-serotonin reuptake inhibithors
05/02/2007CN1956951A Method for producing diphenyl azetidinone derivatives
05/02/2007CN1956946A Modulators of cannabinoid receptors
05/02/2007CN1313439C Compounds and compositions for delivering active agents
05/01/2007US7211696 Antileishmanial dinitroaniline sulfanomides with activity against parasite tubulin
05/01/2007US7211685 Carboxy group, nitro group, tert-butoxycarbonylamino group or benzyloxycarbonylamino substituted naphthalene: osteoporosis, hypoparathyreosis, osteosarcoma, periodontal disease, bone fracture, steoarthrosis, chronic rheumatoid arthritis, Paget's disease, humoral hypercalcemia
05/01/2007US7211667 Trans,trans-1,3-butadiene-1,4-di-n-butyl-1-carboxyl-4-carboxamide; treating hypertension, associated with the decreased binding of magnesium to the plasma membranes of cells
05/01/2007US7211241 Cascade polymer complexes that contain complexing ligands of general formula I A-(X (Y-(Z-(W KW)Z)y)x) (I), in which A stands for a nitrogen-containing cascade nucleus of base multiplicity a, X and Y, independently of one another, stand
05/01/2007CA2143636C Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants
04/2007
04/26/2007WO2007047305A1 Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
04/26/2007US20070093487 Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
04/26/2007US20070093455 10-substituted tetracyclines and methods of use thereof
04/25/2007EP1777246A2 Polymers containing amide groups for controlling rheology
04/25/2007EP1776351A1 Uv filter
04/25/2007CN1312120C Adamantane derivatives
04/24/2007US7208629 5′-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2007US7208601 May be antagonists of the intrinsic clotting pathway by binding to and inhibiting the function of factor XI or of both factors XI and IX; for example, 2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-phenyl-thiophen-2-yl)-propionic acid; anticoagulants
04/24/2007US7208482 9-aminoacyl tetracycline compounds and methods of use thereof
04/24/2007CA2289472C Excitatory amino acid receptor modulators
04/19/2007WO2007044100A1 Methods for preparing glutamic acid derivatives
04/19/2007WO2007009389A3 Substituted propanamide derivatives, preparation and use thereof
04/19/2007WO2007005887A3 Androgen receptor modulator compounds, compositions and uses thereof
04/19/2007WO2006102243A3 Alpha ketoamide compounds as cysteine protease inhibitors
04/19/2007US20070088172 Methods for preparing glutamic acid derivatives
04/19/2007US20070088027 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
04/19/2007CA2624866A1 Methods for preparing glutamic acid derivatives
04/18/2007EP1775283A1 3-aminobenamide compound and vanilloid receptor 1 (vr1) activity inhibitor
04/17/2007US7205436 Process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and / or benzamidoalkylamines
04/17/2007US7205435 Type B botulism toxin inhibitors
04/17/2007US7205336 β-secretase inhibitors
04/17/2007CA2190765C Novel potent inducers of terminal differentiation and methods of use thereof
04/12/2007WO2007039183A1 Sythesis of renin inhibitors involving a cycloaddition reaction
04/12/2007US20070082957 2-chloro-5-(3-oxopropyl)-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide; P2X7 receptor antagonists; inflammatory, immune or cardiovascular diseases
04/12/2007US20070082951 protamine-mimetic compounds; calixarenes substituted with amino acids bearing salifiable amino groups; In post-surgical protocols to prevent thromboembolism, clotting and thrombi; to prevent clotting in dialysis circuits; side effects reduction; minimize the risk of hemorrhage in dialysed patients
04/12/2007US20070082897 Acylated indanyl amines and their use as pharmaceuticals
04/12/2007CA2623495A1 Synthesis of renin inhibitors involving a cycloaddition reaction
04/11/2007EP1771206A2 Lipids, lipid complexes and use thereof
04/11/2007EP1073623B1 Substituted amino acids as erythropoietin mimetics
04/11/2007CN1944398A New benzoyl amide compounds and its preparing method and medicine use
04/11/2007CN1943786A Ester compound and its medicinal application
04/11/2007CN1309760C Poly asparaginyl aminoacetic acid, alanine and lysine and its preparation method and medicament purpose
04/11/2007CN1309704C Anthranyl amides and their use as medicaments
04/11/2007CN1309703C Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
04/10/2007US7202242 Substituted 1 and 2-naphthol Mannich bases
04/10/2007US7202235 Such as 5-propionyl-6-cyclopentylsulfanylmethyl doxycycline; for controlling Cryptosporidium parvum disorders such as diarrhea, particularly in immunodeficient individuals
04/10/2007CA2262367C Anti-bacterial amine derivatives
04/10/2007CA2154477C Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte-aggregation
04/10/2007CA2133991C T-butyl cascade polymers
04/05/2007WO2007037082A1 Process for producing carnitinamide
04/05/2007US20070078281 Mixing pentaacetyliopamidol with methanol and hydrochloric acid,heating,removing the methanol by distillation to form a residue,dissolving residue in water to form a first solution,adding an acid scavenging resin to neutralize the hydrochloric acid solution,filtering; passing solution
04/05/2007US20070078183 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
04/04/2007EP1768955A1 Amide derivatives as inhibitors of histone deacetylase
04/04/2007EP1551793A4 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
04/04/2007CN1942432A Phenylethanolamine derivatives as beta-2 agonists
04/04/2007CN1308292C Succinic acid semi-amides as anti-corrosives agents
04/03/2007US7199268 Process for the production of dendritic trimesic acid triamides
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 162